RESEARCH ARCHIVEMENTS研究実績 論文
論文
2020
国際
Kobayashi G, Sentani K, Babasaki T, Sekino Y, Shigematsu Y, Hayashi T, Oue N, Teishima J, Matsubara A, Sasaki N, Yasui W.
Claspin overexpression is associated with high-grade histology and poor prognosis in renal cell carcinoma.
Cancer Sci. 2020 Jan 7. doi: 10.1111/cas.14299. [Epub ahead of print]
Tomita Y, Naito S, Sassa N, Takahashi A, Kondo T, Koie T, Obara W, Kobayashi Y, Teishima J, Takahashi M, Matsuyama H, Ueda T, Yamaguchi K, Kishida T, Shiroki R, Saika T, Shinohara N, Oya M, Kanayama HO.
Sunitinib versus sorafenib as initial targeted therapy for mCC-RCC with favourable/intermediate risk: multicentre randomised trial CROSS-J-RCC.
Clin Genitourin Cancer, in press.
Teishima J, Murata D, Inoue S, Hayashi T, Mita K, Hasegawa Y, Kato M, Kajiwara M, Shigeta M, Maruyama S, Moriyama H, Fujiwara S, Matsubara A.
Improved prognosis for older-aged patients with metastatic renal cell carcinoma after targeted therapy.
Mol Clin Oncol, 12: 557-564, 2020.
Yamanaka R, Sekino Y, Babasaki T, Kitano H, Ikeda K, Goto K, Hieda K, Inoue S, Hayashi T, Teishima J, Aikata H, Chayama K, Sentani K, Yasui W, Matsubara A.
Renal Metastasis from Primary Hepatocellular Carcinoma: A case report.
Int Cancer Conf J, Mar 25, 2020, Epub.
Sekino Y, Hagura T, Han X, Babasaki T, Goto K, Inoue S, Hayashi T, Teishima J, Shigeta M, Taniyama D, Kuraoka K, Sentani K, Yasui W,Matsubara A.
PTEN is involved in sunitinib and sorafenib resistance in renal cell carcinoma.
Anticancer Res 40:1943-1951, 2020.
Inoue S, Hayashi T, Teishima J, Matsubara A.
Comparative analysis of robot-assisted, laparoscopic, and open radical prostatectomy regarding lower urinary tract symptoms: A longitudinal study.
Urol Sci 31(1): 21-27, 2020.
Inoue S, Hayashi T, Teishima J, Matsubara A.
Prevalence of hand joint symptoms in androgen deprivation therapy among Japanese patients with prostate cancer.
Urol Sci 31(1): 15-20, 2020.
Teishima J.
Editorial comment to Contact with renal sinus tissue is associated with poor prognosis in pathological T1 clear cell renal cell carcinoma treated surgically.
Int J urol, 2020 Aug;27(8):662. doi: 10.1111/iju.14277. Epub 2020 Jun 23.
Sekino Y, Teishima J.
Editorial comments to A rare case of carcinoma in situ originated in right retrocaval ureter successfully managed with laparoscopic procedure.
IJU Case Reports, 2020 May 18;3(4):131-132. doi: 10.1002/iju5.12170. eCollection 2020 Jul.
Sekino Y, Han X, Babasaki T, Goto K, Inoue S, Hayashi T, Teishima J, Shiota M, Takeshima Y, Yasui W, Matsubara A.
Microtubule-associated protein tau (MAPT) promotes bicalutamide resistance and is associated with survival in prostate cancer.
Urol Oncol. 2020 May 16: S1078-1439(20): 30191-30195, 2020.
Sekino Y, Han X, Babasaki T, Miyamoto S, Kitano H, Kobayashi G, Goto K, Inoue S, Hayashi T, Teishima J, Sakamoto N, Sentani K, Oue N, Yasui W, Matsubara A.
TUBB3 is associated with high-grade histology, poor prognosis, p53 expression, and cancer stem cell markers in clear cell renal cell carcinoma.
Oncology, 2020;98(10):689-698. doi: 10.1159/000506775. Epub 2020 Jun 25.
Teishima J, Murata D, Inoue S, Hayashi T, Mita K, Hasegawa Y, Kato M, Kajiwara M, Shigeta M, Maruyama S, Moriyama H, Fujiwara S and Matsubara A.
Prediction of early progression of metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitor
Curr Urol, 2021 Dec;15(4):187-192. doi: 10.1097/CU9.0000000000000042. Epub 2021 Sep 24.
Teishima J, Inoue S, Hayashi T, Mita K, Hasegawa Y, Kato M, Kajiwara M, Shigeta M, Maruyama S, Moriyama H, Fujiwara S, Matsubara A.
Impact of the systemic immune-inflammation index for the prediction of prognosis and modification of the risk model in patients with metastatic renal cell carcinoma treated with 1st line tyrosine kinase inhibitors.
Can Urol Assoc J, 2020 Nov;14(11):E582-E587. doi: 10.5489/cuaj.6413.
Inoue S, Hayashi T, Teishima J, Matsubara A.
Impact of adrenalectomy on cortisol-producing adenoma: longitudinal evaluation of health-related quality of life following laparoscopic adrenalectomy.
Urol Int, 2020;104(9-10):789-796. doi: 10.1159/000508765. Epub 2020 Jul 9.
Inoue S, Hayashi T, Teishima J, Matsubara A.
Effect of penile rehabilitation with low-intensity extracorporeal shock wave therapy on erectile function recovery following robot-assisted radical prostatectomy.
Translational Andrology and Urology, 2020 Aug;9(4):1559-1565. doi: 10.21037/tau-19-888.
Fujii S, Hayashi T, Honda Y, Terada H, Akita R, Kitamura N, Ueda E, Han X, Ueno T, Miyamoto S, Kitano H, Inoue S, Teishima J, Abdi H, Awai K, Takeshima Y, Sentani K, Yasui W, Matsubara A.
Magnetic resonance imaging/transrectal ultrasonography fusion targeted prostate biopsy finds more significant prostate cancer in biopsy-naïve Japanese men compared with the standard biopsy.
Int J Urol. 2020 Feb;27(2):140-146. doi: 10.1111/iju.14149. Epub 2019 Nov 16.
Kitano H, Shigemoto N, Koba Y, Hara T, Seiya K, Omori K, Shigemura K, Teishima J, Fujisawa M, Matsubara A, Ohge H.
Indwelling catheterization, renal stones, and hydronephrosis are risk factors for symptomatic Staphylococcus aureus-related urinary tract infection.
World J Urol. 2020 May 3. doi: 10.1007/s00345-020-03223-x. [Epub ahead of print]
Kobatake K, Ikeda K, Nakata Y, Yamasaki N, Ueda T, Kanai A, Sentani K, Sera Y, Hayashi T, Koizumi M, Miyakawa Y, Inaba T, Sotomaru Y, Kaminuma O, Ichinohe T, Honda Z, Yasui W, Horie S, Black PC, Matsubara A, Honda H
Kdm6a Deficiency Activates Inflammatory Pathways, Promotes M2 Macrophage Polarization, and Causes Bladder Cancer in Cooperation with p53 Dysfunction
Clin Cancer Res. 2020 Apr 15;26(8):2065-2079. doi: 10.1158/1078-0432.CCR-19-2230. Epub 2020 Feb 11.
Inoue S, Hayashi T, Teishima J, Matsubara A.
Prevalence of hand joint symptoms in androgen deprivation therapy among Japanese patients with prostate cancer.
Urol Sci. 2020 Jan-Feb; 31(1): 15-20.
Inoue S, Hayashi T, Teishima J, Matsubara A.
Comparative analysis of robot-assisted, laparoscopic, and open radical prostatectomy regarding lower urinary tract symptoms: A longitudinal study.
Urol Sci. 2020 Jan-Feb; 31(1): 21-27.
Kobayashi G, Sentani K, Babasaki T, Sekino Y, Shigematsu Y, Hayashi T, Oue N, Teishima J, Matsubara A, Sasaki N, Yasui W.
Claspin overexpression is associated with high-grade histology and poor prognosis in renal cell carcinoma.
Cancer Sci. 2020 Jan 7. doi: 10.1111/cas.14299. [Epub ahead of print]
Nakatsu Y, Yamamotoya T, Ueda K, Ono H, Inoue MK, Matsunaga Y, Kushiyama A, Sakoda H, Fujishiro M, Matsubara A, Asano T.
Prolyl isomerase Pin1 in metabolic reprogramming of cancer cells.
Cancer Lett. 2020 Feb 1;470:106-114. doi: 10.1016/j.canlet.2019.10.043. Epub 2019 Oct 31.
Kurimura Y, Haga N, Yanagida T, Tanji R, Onagi A, Honda R, Matsuoka K, Hoshi S, Hata J, Onoda M, Sato Y, Akaihata H, Kataoka M, Ogawa S, Ishibashi K, Matsubara A, Kojima Y.
The preoperative pad test as a predictor of urinary incontinence and quality of life after robot-assisted radical prostatectomy: a prospective, observational, clinical study.
Int Urol Nephrol. 2020 Jan;52(1):67-76. doi: 10.1007/s11255-019-02301-3. Epub 2019 Oct 1.
国内
亭島 淳、福岡憲一郎、北野弘之、井上 省吾、松原 昭郎．
分子標的薬によって予後延長効果を認めた多発転移を伴う進行性腎癌症例.
西日本泌尿器科，82巻2号 Page202-208(2020.06)
亭島 淳．
特集/高齢者の泌尿器科手術．腎癌における手術療法と高齢者における術式選択： 腎摘、腎部分切除、アブレーション、凍結療法．
泌尿器科．11(2): 149-156, 2020.
井上 省吾
治療法の再整理とアップデートのために 専門家による私の治療 尿膜管嚢胞、尿膜管腫瘍(解説)
日本医事新報 (0385-9215)4995号 Page45(2020.01)
2019
国際
Honda Y, Nakamura Y, Teishima J, Goto K, Higaki T, Narita K, Akagi M, Terada H, Kaichi Y, Fujii S, Hayashi T, Matsubara A, Sentani K, Yasui W,
Clinical staging of upper urinary tract urothelial carcinoma for T staging: Review and pictorial essay.
Int J Urol. 2019 Nov;26(11):1024-1032. doi: 10.1111/iju.14068. Epub 2019 Aug 4.
Kitano H, Teishima J, Shigemura K,Ohge H ,Fujisawa M ,Matsubara A.
Current Status of Countermeasures for Infectious Diseases and Resistant Microbes in the Field of Urology.
Int J Urol. 2019 Dec;26(12):1090-1098.doi: 10.1111/iju.14087. Epub 2019 Aug 5.
Mita K, Kobatake K, Ohara S, Kato M, Nomura N, Murata D, Mochizuki H.
Second Transurethral Resection (TUR) for Bladder Cancer Diagnosed with High Grade pT1 by Initial TUR Under Narrow Band Imaging].
Hinyokika Kiyo. 2019 Dec;65(12):501-506. doi: 10.14989/ActaUrolJap_65_12_501.
Teishima J, Hayashi T, Kitano H, Sadahide K, Sekino Y, Goto K, Inoue S, Honda Y, Sentani K, Awai K, Yasui W, Matsubara A.
Impact of radiological morphology of clinical T1 renal cell carcinoma on the prediction of upstaging to pathological T3.
Jpn J Clin Oncol. 2020 Feb 26. pii: hyz154. doi: 10.1093/jjco/hyz154. [Epub ahead of print]
Kenichiro Fukuoka,Jun Teishima,Hirotaka Nagamatsu,Shogo Inoue,Tetsutaro Hayashi,Koji Mita,Masanobu Shigeta,Kanao Kobayashi,Mitsuru Kajiwara,Yuichi Kadonishi,Takatoshi Tacho,Akio Matsubara.
Predictors of poor response to first‐generation anti‐androgens as criteria for alternate treatments for patients with non‐metastatic castration‐resistant prostate cancer.
International Urology and Nephrology https://doi.org/10.1007/s11255-019-02281-4. Received: 21 June 2019 / Accepted: 10 September 2019
Fujii S, Hayashi T, Honda Y, Terada H, Akita R, Kitamura N, Ueda E, Han X, Ueno T, Miyamoto S, Kitano H, Inoue S, Teishima J, Abdi H, Awai K, Takeshima Y, Sentani K, Yasui W, Matsubara A.
Magnetic resonance imaging/transrectal ultrasonography fusion targeted prostate biopsy finds more significant prostate cancer in biopsy-naïve Japanese men compared with the standard biopsy.
Int J Urol. 2019 Nov 16. doi: 10.1111/iju.14149. [Epub ahead of print]
Sekino Y, Han X, Kawaguchi T, Babasaki T, Goto K, Inoue S, Hayashi T, Teishima J, Shiota M, Yasui W, Matsubara A.
TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer.
Int J Mol Sci. 2019 Aug 13;20(16). pii: E3936. doi: 10.3390/ijms20163936.
Teishima J, Murata D, Hasegawa Y, Moriyama H, Mita K, Matsubara A.
C-reactive protein can be used to predict the therapeutic effects of nivolumab in patients with metastatic renal cell carcinoma.
Int J Urol 26: 1076-1077, 2019.
Kitano H, Teishima J, Shigemura K, Ohge H, Fujisawa M, Matsubara A.
Current status of countermeasures for infectious diseases and resistant microbes in the field of urology.
Int J Urol. 2019 Dec;26(12):1090-1098. doi: 10.1111/iju.14087. Epub 2019 Aug 5. Review.
Honda Y, Nakamura Y, Teishima J, Goto K, Higaki T, Narita K, Akagi M, Terada H, Kaichi Y, Fujii S, Hayashi T, Matsubara A, Sentani K, Yasui W, Iida M, Awai K.
Clinical staging of upper urinary tract urothelial carcinoma for T staging: Review and pictorial essay.
Int J Urol. 2019 Nov;26(11):1024-1032. doi: 10.1111/iju.14068. Epub 2019 Aug 4. Review.
Mukai S, Shinmei S, Muto M, Hatayama T, Shikuma H, Miyamoto S, Fujii S, Sadahide K, Sekino Y, Hieda K, Inoue S, Hayashi T, Teishima J, Matsubara A.
Refractory fistula of bladder repaired with transurethral cystoscopic injection of N‐butyl‐2‐cyanoacrylate.
IJU Case Rep, 2019. https://doi.org/10.1002/iju5.12130
Teishima J, Murata D, Hasegawa Y, Moriyama H, Mita K, Matsubara A.
C-reactive protein can be used to predict the therapeutic effects of nivolumab in patients with metastatic renal cell carcinoma.
Int J Urol. 2019 Nov;26(11):1076-1077. doi: 10.1111/iju.14084. Epub 2019 Jul 31. No abstract available.
Teishima J, Matsubara A.
Editorial Comment to Current status and future perspective of robot-assisted radical cystectomy for invasive bladder cancer.
Int J Urol. 2019 Nov;26(11):1042-1043. doi: 10.1111/iju.14086. Epub 2019 Jul 30. No abstract available.
Sekino Y, Sakamoto N, Sentani K, Oue N, Teishima J, Matsubara A, Yasui W.
miR-130b Promotes Sunitinib Resistance through Regulation of PTEN in Renal Cell Carcinoma.
Oncology. 2019;97(3):164-172. doi: 10.1159/000500605. Epub 2019 Jun 13.
Shikuma H, Inoue S, Hatayama T, Mukai S, Muto M, Miyamoto S, Sadahide K, Fujii S, Sekino Y, Goto K, Shinmei S, Hieda K, Hayashi T, Teishima J, Matsubara A.
Pneumatosis cystoides intestinalis linked to sunitinib treatment for renal cell carcinoma.
IJU Case Rep, 2019. https://doi.org/10.1002/iju5.12119
Hatayama T, Sekino Y, Shikuma H, Mukai S, Muto M, Miyamoto S, Sadahide K, Fukuoka K, Fujii S, Goto K, Shinmei S, Hieda K, Inoue S, Hayashi T, Teishima J, Kuroda N, Sentani K, Yasui W, Matsubara A.
Case of renal mucinous tubular and spindle cell carcinoma with high nuclear grade.
IJU Case Rep 2 (4), 2019. https://doi.org/10.1002/iju5.12075
Shigematsu Y, Oue N, Sekino Y, Sakamoto N, Sentani K, Uraoka N, Hayashi T, Teishima J, Matsubara A, Yasui W.
SEC11A Expression Is Associated with Basal-Like Bladder Cancer and Predicts Patient Survival.
Pathobiology. 2019;86(4):208-216. doi: 10.1159/000497206. Epub 2019 Jun 4.
Teishima J, Matsubara A.
Editorial Comment to Recent advances in the systemic treatment of metastatic non-clear cell renal cell carcinomas.
Int J Urol. 2019 Sep;26(9):877. doi: 10.1111/iju.14032. Epub 2019 May 30. No abstract available.
Ueda K, Nakatsu Y, Yamamotoya T, Ono H, Inoue Y, Inoue MK, Mizuno Y, Matsunaga Y, Kushiyama A, Sakoda H, Fujishiro M, Takahashi SI, Matsubara A, Asano T.
Prolyl isomerase Pin1 binds to and stabilizes acetyl CoA carboxylase 1 protein, thereby supporting cancer cell proliferation.
Oncotarget. 2019 Feb 26;10(17):1637-1648. doi: 10.18632/oncotarget.26691. eCollection 2019 Feb 26.
Hayami H, Takahashi S, Ishikawa K, Yasuda M, Yamamoto S, Wada K, Kobayashi K, Hamasuna R, Minamitani S, Matsumoto T, Kiyota H, Tateda K, Sato J, Hanaki H, Masumori N, Nishiyama H, Miyazaki J, Fujimoto K, Tanaka K, Uehara S, Matsubara A, Ito K, Hayashi K, Kurimura Y, Ito S, Takeuchi T, Narita H, Izumitani M, Nishimura H, Kawahara M, Hara M, Hosobe T, Takashima K, Chokyu H, Matsumura M, Ihara H, Uno S, Monden K, Sumii T, Kawai S, Kariya S, Sato T, Yoshioka M, Kadena H, Matsushita S, Nishi S, Hosokawa Y, Shirane T, Yoh M, Watanabe S, Makinose S, Uemura T, Goto H.
Second nationwide surveillance of bacterial pathogens in patients with acute uncomplicated cystitis conducted by Japanese Surveillance Committee from 2015 to 2016: antimicrobial susceptibility of Escherichia coli, Klebsiella pneumoniae, and Staphylococcus saprophyticus.
J Infect Chemother. 2019 Jun;25(6):413-422. doi: 10.1016/j.jiac.2019.02.021. Epub 2019 Mar 21.
Kenichiro Fukuoka,Jun Teishima,Hirotaka Nagamatsu,Shogo Inoue,Tetsutaro Hayashi,Koji Mita,Masanobu Shigeta,Kanao Kobayashi,Mitsuru Kajiwara,Yuichi Kadonishi,Takatoshi Tacho,Akio Matsubara.
Predictors of poor response to first‐generation anti‐androgens as criteria for alternate treatments for patients with non‐metastatic castration‐resistant prostate cancer.
International Urology and Nephrology https://doi.org/10.1007/s11255-019-02281-4. Received: 21 June 2019 / Accepted: 10 September 2019
Teishima J, Inoue S, Hayashi T, Matsubara A.
Current status of prognostic factors in patients with metastatic renal cell carcinoma.
Int J Urol, 26(6):608-617, 2019
Fukuoka K, Wilting J, Rodríguez-Vázquez JF, Murakami G, Ishizawa A, Matsubara A.
The Embryonic Ascent of the Kidney Revisited.
Anat Rec (Hoboken). 2019 Feb;302(2):278-287. doi: 10.1002/ar.23930. Epub 2018 Nov 19.
Sekino Y, Oue N, Mukai S, Shigematsu Y, Goto K, Sakamoto N, Sentani K, Hayashi T, Teishima J, Matsubara A, Yasui W.
Protocadherin B9 promotes resistance to bicalutamide and is associated with the survival of prostate cancer patients.
Prostate. 2019 Feb;79(2):234-242. doi: 10.1002/pros.23728. Epub 2018 Oct 16.
Inoue S, Hayashi T, Hieda K, Shinmei S, Teishima J, Matsubara A.
Longitudinal analysis of laparoendoscopic single-site adrenalectomy and conventional laparoscopic adrenalectomy regarding patient-reported satisfaction and cosmesis outcomes.
Asian J Surg. 2019 Mar;42(3):514-519. doi: 10.1016/j.asjsur.2018.10.002. Epub 2018 Nov 13.
Teishima J, Matsubara A.
Editorial Comment to Utility of robot-assisted radical cystectomy with intracorporeal urinary diversion for muscle-invasive bladder cancer.
Int J Urol. 2019 Mar;26(3):340-341. doi: 10.1111/iju.13906. Epub 2019 Jan 28.
Teishima J, Matsubara A.
Editorial Comment to Current status and future perspective of robot-assisted radical cystectomy for invasive bladder cancer.
Int J Urol 26:1042-1043, 2019.
Teishima J, Matsubara A.
Editorial Comment to Peritumoral pseudocapsule status according to pathological characteristics from robot-assisted laparoscopic partial nephrectomy for localized renal cell carcinoma.
Int J Urol. 2019 Jan 18. doi: 10.1111/iju.13904. [Epub ahead of print].
Teishima J, Matsubara A.
Editorial Comment to “At-risk” kidney: How surgical factors influence renal functional preservation after partial nephrectomy.
Int J Urol. 2019 Feb 28. doi: 10.1111/iju.13937. [Epub ahead of print]
Sekino Y, Sakamoto N, Ishikawa A, Honma R, Shigematsu Y, Hayashi T, Sentani K, Oue N, Teishima J, Matsubara A, Yasui W.
Transcribed ultraconserved region Uc.63+ promotes resistance to cisplatin through regulation of androgen receptor signaling in bladder cancer.
Oncol Rep. 2019 Feb 28. doi: 10.3892/or.2019.7039. [Epub ahead of print]
Teishima J, Hayashi T, Nagamatsu H, Shoji K, Shikuma H, Yamanaka R, Sekino Y, Goto K, Inoue S, Matsubara A
Fibroblast Growth Factor Family in the Progression of Prostate Cancer.
J Clin Med. 2019 Feb 4;8(2). pii: E183. doi: 10.3390/jcm8020183.
Sekino Y, Oue N, Koike Y, Shigematsu Y, Sakamoto N, Sentani K, Teishima J, Shiota M, Matsubara A, Yasui W.
KIFC1 Inhibitor CW069 Induces Apoptosis and Reverses Resistance to Docetaxel in Prostate Cancer.
J Clin Med. 2019 Feb 9;8(2).pii: E225. doi: 10.3390/jcm8020225.
国内
亭島 淳．
特集 まるごと 患者開設に使える図解シートつき！保存版泌尿器内視鏡手術．７腹腔鏡下腎部分切除術・ロボット支援腎部分切除術．
Uro-Lo，24(5):31-34，2019.
亭島 淳．
特集 まるごと 泌尿器科あるある！術中・術後のトラブル＆リカバリー．腎部分切除術後にかかわるトラブル＆リカバリー．
Uro-Lo，24(6):17-19，2019.
亭島 淳，松原昭郎．
特集 どう変わった？腎細胞がんの診療．6．組織型別にみた標準的薬物治療ー今、腎細胞がんに用いられているレジメンはこれ．１）一次治療における標準的選択肢．
臨床腫瘍プラクティス， 15(4):251-256，2019.
亭島 淳．
特集 まるごと 泌尿器科エキスパートに学ぶ！術式の選択基準と周術期アセスメント．12 陰茎がん．
Uro-Lo，24(2):61-64，2019.
亭島 淳，松原昭郎．
特集 ハイリスク前立腺癌を深掘りするーその変遷とM0CRPCの最新治療．局所ハイリスク前立腺癌における課題．局所ハイリスク前立腺癌における手術：拡大リンパ節郭清．
臨床泌尿器科，73(8):516-520，2019．
松原 昭郎
前立腺癌実地診療 Retzius腔温存ロボット支援前立腺全摘除術について教えてください
Prostate Cancer Front Line Vol.8 No1 2019.JULY 12-16
井上 省吾
泌尿器科周術期パーフェクト管理】腫瘍関連の手術:膀胱 腹腔鏡下尿膜管摘除術(解説/特集)
臨床泌尿器科 (0385-2393)73巻4号 Page087-090(2019.04)
井上 省吾
【副腎腫瘍に対する低侵襲治療のさらなる進歩】単孔式腹腔鏡下副腎摘除術 整容性の観点からの検証(解説/特集)
日本内分泌外科学会雑誌 (2434-6535)36巻1号 Page29-33(2019.03)
2018
国際
Yohei Sekino, Naoya Sakamoto, Keisuke Goto, Ririno Honma, Yoshinori Shigematsu, Thang Pham Quoc, Kazuhiro Sentani, Naohide Oue, Jun Teishima, Fumi Kawakami, Jose A Karam, Kanishka Sircar,Akio Matsubara,and Wataru Yasui
Uc.416 + A promotes epithelial-to-mesenchymal transition through miR-153 in renal cell carcinoma.
BMC Cancer. 2018 Oct 4;18(1):952. doi: 10.1186/s12885-018-4863-y.
2. Sadahide K, Teishima J, Inoue S, Tamura T, Kamei N, Adachi N, Matsubara A.
Endoscopic repair of the urinary bladder with magnetically labeled mesenchymal stem cells: Preliminary report.
Regen Ther. 2018 Dec 17;10:46-53. doi: 10.1016/j.reth.2018.10.007. eCollection 2019 Jun.
3. Yuki Kohada, Tetsutaro Hayashi, Keisuke Goto, Kohei Kobatake, Hamidreza Abdi, Yukiko Honda, Kazuhiro Sentani, Shogo Inoue,Jun Teishima, Kazuo Awai, Wataru Yasui, and Akio Matsubara.
Preoperative risk classification using neutrophil-lymphocyte ratio and hydronephrosis for upper tract urothelial carcinoma.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY 2018 Sep-18 28(9) 841-849 10.1093/jjco/hyy084
5. Ito K, Saito S, Yorozu A, Kojima S, Kikuchi T, Higashide S, Aoki M, Koga H, Satoh T, Ohashi T, Nakamura K, Katayama N, Tanaka N, Nakano M, Shigematsu N, Dokiya T, Fukushima M; J-POPS Investigators.
Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS): first analysis on survival.
Int J Clin Oncol. 2018 Jun 22. doi: 10.1007/s10147-018-1309-0. [Epub ahead of print]
6. Teishima J, Matsubara A.
Editorial Comment from Dr Teishima and Dr Matsubara to Prognostic impact of the pretreatment aspartate transaminase/alanine transaminase ratio in patients treated with first-line systemic tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma.
Int J Urol. 2018 May 13. doi: 10.1111/iju.13592. [Epub ahead of print]
7. Teishima J, Takayama Y, Iwaguro S, Hayashi T, Inoue S, Hieda K, Shinmei S, Kato R, Mita K, Matsubara A.
Usefulness of personalized three-dimensional printed model on the satisfaction of preoperative education for patients undergoing robot-assisted partial nephrectomy and their families.
Int Urol Nephrol. 2018 May 9. doi: 10.1007/s11255-018-1881-2. [Epub ahead of print]
8. Yuki Kohada, Tetsutaro Hayashi, Keisuke Goto, Kohei Kobatake, Hamidreza Abdi, Yukiko Honda, Kazuhiro Sentani, Shogo Inoue,Jun Teishima, Kazuo Awai, Wataru Yasui, and Akio Matsubara.
Preoperative risk classification using neutrophil-lymphocyte ratio and hydronephrosis for upper tract urothelial carcinoma.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY 2018 Sep-18 28(9) 841-849 10.1093/jjco/hyy084
9. Akihiro Goriki, Roland Seiler, Alexander W. Wyatt, Alberto Contreras-Sanz, Akshay Bhat, Akio Matsubara, Tetsutaro Hayashi & Peter C. Black.
Unravelling disparate roles of NOTCH in bladder cancer.
NATURE REVIEWS UROLOGY Jun-18 15（6） 345-357 10.1038/s41585-018-0005-1
10. Tanaka K, Teishima J, Takenaka A, Shiroki R, Kobayashi Y, Hattori K, Kanayama HO, Horie S, Yoshino Y, Fujisawa M.
Prospective study of robotic partial nephrectomy for renal cancer in Japan: Comparison with a historical control undergoing laparoscopic partial nephrectomy.
Int J Urol. 2018 May;25(5):472-478. doi: 10.1111/iju.13544. Epub 2018 Apr 19
11. Shogo Matsui,Masato Kajikawa,Tatsuya Maruhash,Yumiko Iwamoto,,NozomuOda,Shinji Kishimoto,Haruki Hashimoto,TakayukiHidaka,Yasuki Kihara,Kazuaki Chayama,Eisuke Hida,ChikaraGoto,Yoshiki Aibara,Ayumu Nakashima,Farina Mohamad Yusoff, Kensuke Noma,Yoshitaka Kuwahara,Akio Matsubara,Yukihito Higashi.
Endothelial dysfunction, abnormal vascular structure and lower urinary tract symptoms in men and women.
International Journal of Cardiology.2018,261,196-203
12. Narita M, Kageyama S, Okegawa T, Kinoshita H, Sato F, Nakagawa K, Habuchi T, Hoshi A, Matsubara A, Yoshimura K, Terachi T, Mimata H, Kawauchi A.
Urological laparo-endoscopic single-site and reduced port surgery: a nationwide survey in Japan.
Int J Urol.2018(25),263-268.DOI:10.1111/iju.13504
国内
15. 北野 弘之, 梶原 俊毅, 石崎 康代, 立山 義朗, 亭島 淳, 大毛 宏喜, 松原 昭郎
梅毒性肝炎とリンパ節炎を伴った早期梅毒の1例
日本性感染症学会誌 2018 29（1） 37-42
16. 林 哲太郎, 神明 俊輔, 後藤 景介, 稗田 圭介, 井上 省吾, 亭島 淳, 松原 昭郎
泌尿器がんにおける抗体薬物複合体治療の可能性
西日本泌尿器科 2018 80（11） 567-571
17. 村上 祐司, 勝田 剛, 亭島 淳, 今野 伸樹, 竹内 有樹, 高橋 一平, 西淵 いくの, 木村 智樹, 松原 昭郎, 永田 靖
T1-3N0M0前立腺癌に対する強度変調放射線治療の中期治療成績
広島医学 2018 71（10） 663-668
18. 西田 健介, 藤井 慎介, 林 哲太郎, 上野 剛志, 岩根 亨輔, 田坂 亮, 栗村 嘉昌, 定秀 孝介, 福岡 憲一郎, 稗田 圭介, 神明 俊輔, 井上 省吾, 亭島 淳, 松原 昭郎
MRI-TRUS融合画像リアルタイムガイド下前立腺生検の有用性 狙撃生検は診断精度を向上させる
泌尿器外科 2018 31（8） 1197-1200
13. 井上 省吾
【性機能障害と腎泌尿器疾患】ロボット支援前立腺全摘除術と術後性機能障害(解説/特集)
腎臓内科・泌尿器科 (2188-9147)8巻3号 Page217-224(2018.09)
14. 亭島 淳, 井上 省吾, 稗田 圭介, 神明 俊輔, 林 哲太郎, 松原 昭郎
進化しつつある腎細胞がん治療-プレシジョンメディスンに向けて- ロボット支援腎部分切除術 症例ごとの最適な対応(解説)
日本腎泌尿器疾患予防医学研究会誌 2018 26（1） 39-42
19. 稗田 圭介, 神明 俊輔, 井上 省吾, 松原 昭郎
泌尿器科領域におけるトラブルシューティング(第90回) ロボット支援腹腔鏡下根治的前立腺全摘除術における異なる経過をたどったカメラポート作成時消化管損傷
泌尿器外科 2018 31（4） 387-389
20. 井上 省吾, 亭島 淳, 松原 昭郎
がん薬物療法の副作用 : 膀胱癌 : BCG療法 (特集 この1冊で安心! 泌尿器科当直医マニュアル : 外来編)
臨床泌尿器科 2018 72(3) 279-283
21. 井上 省吾, 亭島 淳, 松原 昭郎
【泌尿器内視鏡手術のすべて】副腎・腎・後腹膜の手術 単孔式腹腔鏡下副腎摘除術(右・左)
臨床泌尿器科 2018 72(4) 37-46
22. 亭島 淳, 林 哲太郎, 藤井 慎介, 井上 省吾, 稗田 圭介, 神明 俊輔, 松原 昭郎
超高齢時代の筋層浸潤性膀胱癌に対する低侵襲手術 ロボット支援根治的膀胱全摘除術 高齢者への導入
西日本泌尿器科 2018 80(4) 145-149
2017
国際
1. Kishida N, Sentani K, Terada H, Honda Y, Goto K, Hatanaka Y, Kohashi K, Oda Y, Iwata J, Yasui W, Shinmei S, Hayashi T, Teishima J, Matsubara A, Nakamura Y, Iida M, Awai K.
Anastomosing haemangioma with fatty changes in the perirenal space: a lesion mimicking liposarcoma.
BJR Case Rep. 2017 Nov 1;4(2):20170022. doi: 10.1259/bjrcr.20170022. eCollection 2018.
2. Izumi K, Mizokami A, Namiki M, Inoue S, Tanaka N, Yoshio Y, Ishibashi K, Kamiyama M, Kawai N, Enokida H, Shima T, Takahara S.
Enzalutamide versus abiraterone as a first-line endocrine therapy for castration-resistant prostate cancer (ENABLE study for PCa): a study protocol for a multicenter randomized phase III trial.
BMC Cancer. 2017 Oct 10; 17(1):677. doi: 10.1186/s12885-017-3661-2.PMID: 29017493
3. Kobatake K, Hayashi T, Black PC, Goto K, Sentani K, Kaneko M, Yasui W, Mita K, Teishima J, Matsubara A.
Chronic kidney disease as a risk factor for recurrence and progression in patients with primary non-muscle-invasive bladder cancer.
Int J Urol. 2017 Aug;24(8):594-600.
4. Honda Y, Goto K, Nakamura Y, Terada H, Sentani K, Yasui W, Sekino Y, Hayashi T, Teishima J, Matsubara A, Fuji T, Kaichi Y, Higaki T, Baba Y, Iida M, Awai K.
Imaging features of papillary renal cell carcinoma with cystic change-dominant appearance in the era of the 2016 WHO classification.
Abdom Radiol (NY). 2017 Jul;42(7):1850-1856.
5. Pham QT, Oue N, Yamamoto Y, Shigematsu Y, Sekino Y, Sakamoto N, Sentani K, Uraoka N, Tiwari M, Yasui W.
The Expression of BTS-2 Enhances Cell Growth and Invasiveness in Renal Cell Carcinoma.
Anticancer Res. 2017 Jun;37(6):2853-2860.
6. Sekino Y, Sakamoto N, Goto K, Honma R, Shigematsu Y, Sentani K, Oue N,Teishima J, Matsubara A, Yasui W.
Transcribed ultraconserved region Uc.63+promotes resistance to docetaxel through regulation of androgen receptorsignaling in prostate cancer.
Oncotarget. 2017 Oct 9;8(55):94259-94270.
7. Shoji K, Teishima J, Hayashi T, Shinmei S, Akita T, Sentani K, Takeshima Y, Arihiro K, Tanaka J, Yasui W, Matsubara A.
A comparison of clinicopathological features and prognosis in prostate cancer between atomic bomb survivors and control patients.
Oncol Lett. 2017 Jul;14(1):299-305. doi: 10.3892/ol.2017.6119. Epub 2017 May 4.
8. Kitano H, Kitadai Y, Teishima J, Yuge R, Shinmei S, Goto K, Inoue S, Hayashi T, Sentani K, Yasui W, Matsubara A.
Combination therapy using molecular-targeted drugs modulates tumor microenvironment and impairs tumor growth in renal cell carcinoma.
Cancer Med.2017 Oct;6(10)2308-2320
9. Narita M, Kageyama S, Okegawa T, Kinoshita H, Sato F, Nakagawa K, Habuchi T, Hoshi A, Matsubara A, Yoshimura K, Terachi T, Mimata H, Kawauchi A.
Urological laparoendoscopic single-site and reduced port surgery: A nationwide survey in Japan.
Int J Urol. 2017,6-Dec.doi: 10.1111/iju.13504. [Epub ahead of print]
10. Akio Matsubara.
IJU this issue.
International Journal of Urology.(2017) 24,411
11. Jun Teishima,Kohei Kobatake,Shunsuke Shinmei, Shogo Inoue, Tetsutaro Hayashi, Shinya Ohara,Koji Mita,Yasuhisa Hasegawa,Satoshi Maruyama,Mitsuru Kajiwara,Masanobu Shigeta, Hideki Mochizuki,Hiroyuki Moriyama,Seiji Fujiwara,Akio Matsubara.
The effect of kinetics of C-reactive protein in the prediction of overall survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor.
Urol Oncol. 2017 Nov;35(11):662.e1-662.e7. doi: 10.1016/j.urolonc.2017.07.008. Epub 2017 Aug 1.
12. Teishima J, Ohara S, Sadahide K, Fujii S, Kitano H, Kobatake K, Shinmei S, Hieda K, Inoue S, Hayashi T, Mita Matsubara A.
Impact of neutrophil-to-lymphocyte ratio on effects of targeted therapy for metastatic renal cell carcinoma patients with extrapulmonary metastasis.
CUAJ • May 2017 • Volume 11, Issue 5.
13. Teishima J, Matsubara A.
Editorial Comment from Dr Teishima and Dr Matsubara to Estimated glomerular filtration rate on postoperative day 1 is associated with renal functional outcome after percutaneous renal cryoablation for renal tumors.
International Journal of Urology (2017) DOI: 10.1111/iju.13377
14. Inoue S, Kurimura Y, Sadahide K, Hayashi T, Teishima J, Higashi Y, Matsubara A.
Low-intensity extracorporeal shock wave therapy for patients with severe erectile dysfunction due to radical prostatectomy.
Ann Res Hosp 2017;1:2 doi: 10.21037/arh.2017.04.02
15. Kohada Y, Teishima J,Hattori Y, Kurimura Y, Fujii S, Sadahide K, Fukuoka K, Ueno T, Kitano H, Goto K, Hieda K, Shinmei S, Sentani K, Inoue S, Hayashi T, Yasui W, Matsubara A.
Serous adenocarcinoma of retroperitoneum: a case report.
Int Canc Conf J. 2017,doi: 10.1007/s13691-017-0296-8
16. Goto K, Nagamatsu H, Teishima J, Kohada Y, Fujii S, Kurimura Y, Mita K, Shigeta M, Maruyama S, Inoue Y, Nakahara M, Matsubara A.
Bodymass index as a classifier to predict biochemical recurrence after radical prostatectomy in patients with lower prostate-specific antigen levels.
MOLECULAR AND CLINICAL ONCOLOGY. 2017,(6),748-752.
17. Teishima J, Matsubara A.
Editorial Comment from Dr Teishima and Dr Matsubara to Clinical application of calculated split renal volume using computed tomography-based renal volumetry after partial nephrectomy: Correlation with technetium-99m dimercaptosuccinic acid renal scan data.
Int J Urol. 2017 Apr 18. doi: 10.1111/iju.13355. [Epub ahead of print]
18. Teishima J.
Editorial Comment to Surgical treatment of renal cell carcinoma: Can morphological features of inferior vena cava tumor thrombus on computed tomography or magnetic resonance imaging be a prognostic factor?
Int J Urol.2017, Feb;24(2)110,doi:10.1111/iju.13293
19. Teishima J,Matsubara A.
Editorial Comment to Improved technique for intracorporeal neobladder-urethral anastomosis in laparoscopic radical cystectomy.
Int J Urol.2017,[Epub ahead of print],doi: 10.1111/iju.13304.
20. Sato F, Nakagawa K, Kawauchi A, Matsubara A, Okegawa T, Habuchi T, Yoshimura K, Hoshi A, Kinoshita H, Miyajima A, Naitoh Y, Inoue S, Itaya N, Narita S, Hanai K, Okubo K, Yanishi M, Matsuda T, Terachi T, Mimata H.
Laparoendoscopic single-site surgeries: A multicenter experience of 469 cases in Japan.
Int J Urol.2017,Jan;24(1):69-74.doi: 10.1111/iju.13235.
21. Sekino Y, Oue N, Shigematsu Y, Ishikawa A, Sakamoto N, Sentani K, Teishima J, Matsubara A, Yasui W.
KIFC1 induces resistance to docetaxel and is associated with survival of patients with prostate cancer.
Urol Oncol. 2017 Jan;35(1):31.e13-31.e20. doi: 10.1016/j.urolonc.2016.08.007.
22. Inoue S, Miyamoto K, Shinmei S, Shoji K, Teishima J, Sentani K, Yasui W, Matsubara A.
Regeneration of rat corpora cavernosa tissue by transplantation of CD133 + cells derived from human bone marrow and placement of biodegradable gel sponge sheet.
Asian J Androl. 2017 Mar-Apr;19(2):203-207. doi: 10.4103/1008-682X.179155.
23. Kamba T, Kamoto T, Maruo S, Kikuchi T, Shimizu Y, Namiki S, Fujimoto K, Kawanishi H, Sato F, Narita S, Satoh T, Saito H, Sugimoto M, Teishima J, Masumori N, Egawa S, Sakai H, Okada Y, Terachi T, Ogawa O; ZAPCA Study Group.
A phase III multicenter, randomized, controlled study of combined androgen blockade with versus without zoledronic acid in prostate cancer patients with metastatic bone disease: results of the ZAPCA trial.
Int J Clin Oncol. 2017 Feb;22(1):166-173.
24. Bernhard Kiss, Alexander W. Wyatt, James Douglas, Veronika Skuginna,Fan Mo, Shawn Anderson, Diana Rotzer, Achim Fleischmann, Vera Genitsch, Tetsutaro Hayashi, Maja Neuenschwander, Christine Buerki, Elai Davicioni, Colin Collins, George N. Thalmann, Peter C. Black& Roland Seiler.
Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapy.
Scientific Reports.2017 7:42713,doi:10.1038/srep42713
国内
25. 福岡憲一郎、小羽田悠貴、松崎信治、栗村嘉昌、上野剛志、北野弘之、岩本秀雄、神明俊輔、稗田圭介、井上省吾、大原慎也、林哲太郎、亭島淳、三田耕司、繁田正信、松原昭郎
化学療法未施行の去勢抵抗性前立腺癌に対する新規アンドロゲンレセプターシグナル阻害薬の治療成績（多施設共同研究）
西日本泌尿器科．2017. 79. p. 333-8.
33. 亭島淳 井上省吾 池田健一郎 稗田圭介 神明俊輔 林哲太郎 松原昭郎 大原信也 加藤昌生 三田耕司.
術前慢性腎臓病stageが腹腔鏡下・ロボット支援腎部分切除術の術後腎機能低下に及ぼす影響.
西日本泌尿器科別冊,2017,79巻8号
26. 亭島淳
ロボット支援前立腺全摘除術
第100回 日本泌尿器科学会 山口地方会 西日本泌尿器科別冊.2017 5月第79巻5号160
27. 松原 昭郎
教育委員会報告
日本泌尿器科学会雑誌,2017,108巻3号巻末
28. 林哲太郎 後藤景介 神明俊輔 井上省吾 亭島淳 松原 昭郎
膀胱癌のサブタイプ分類と分子標的治療への試み
西日本泌尿器科別冊,2017,79巻9号423-428
29. 亭島淳、松原昭郎
尿管皮膚瘻のストーマ管理
臨床泌尿器科.2017,第71巻 第12号 997-1001
30. 亭島淳、松原昭郎
前立腺癌とメタボリック症候群
泌尿器外科.2017,30(2),123-127
31. 松原昭郎
内科医が知っておきたい泌尿器疾患ー過活動膀胱
広島市内科医会報. 2017,80,19-23
32. 亭島淳 松原昭郎
新腎・泌尿器癌（上）-基礎・臨床研究の進歩- 腎癌 Ⅵ.臨床応用を目指した基礎研究 限局性腎癌のバイオマーカー
日本臨床.2017, 75巻 増刷号6
2016
国際
1. Inoue S.
Reply. Needlescopic-assisted laparoendoscopic single-site adrenalectomy.
Asian J Surg.2016, Apr;39(2):123.
2. Takahashi S, Hamasuna R, Yasuda M, Ishikawa K, Hayami H, Uehara S, Yamamoto S, Minamitani S, Kadota J, Iwata S, Kaku M, Watanabe A, Sato J, Hanaki H, Masumori N, Kiyota H, Egawa S, Tanaka K, Arakawa S, Fujisawa M, Kumon H, Wada K, Kobayashi K, Matsubara A, Matsumoto T, Eto M, Tatsugami K, Kuroiwa K, Ito K, Hosobe T, Hirayama H, Narita H, Yamaguchi T, Ito S, Sumii T, Kawai S, Kanokogi M, Kawano H, Chokyu H, Uno S, Monden K, Kaji S, Kawahara M, Takayama K, Ito M, Yoshioka M, Kano M, Konishi T, Kadena H, Nishi S, Nishimura H, Yamauchi T, Maeda S, Horie M, Ihara H, Matsumura M, Shirane T, Takeyama K, Akiyama K, Takahashi K, Ikuyama T, Inatomi H, Yoh M.
Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan.
J Infect Chemother.2016,Sep;22(9),581-6,doi: 10.1016/j.jiac.2016.06.010.
3. Matsubara A.
IJU this issue.
Int J Urol.2016,23:905.doi:10.1111/iju.13238.
4. Kawano Y, Takahashi W, Eto M, Kamba T, Miyake H, Fujisawa M, Kamai T, Uemura H, Tsukamoto T, Azuma H, Matsubara A, Nishimura K, Nakamura T, Ogawa , Naito S.
Prognosis of metastatic renal cell carcinoma with first-line interferon-α therapy in the era of molecular-targeted therapy.
Cancer Sci.2016,Jul;107(7):1013-7,doi: 10.1111/cas.12951.
5. Ikeda K, Ueda T, Yamasaki N, Nakata Y, Sera Y, Nagamachi A, Miyama T, Kobayashi H, Takubo K, Kanai A, Oda H, Wolff L, Honda Z, Ichinohe T, Matsubara A, Suda T, Inaba T, Honda H.
Maintenance of the functional integrity of mouse hematopoiesis by EED and promotion of leukemogenesis by EED haploinsufficiency.
Scientific Reports. 2016 6;29454.
6. Hayashi T, Gust KM, Wyatt AW, Goriki A, Jäger W, Awrey S, Li N, Oo HZ, Altamirano-Dimas M, Buttyan R, Fazli L, Matsubara A, Black PC.
Not all NOTCH Is Created Equal: The Oncogenic Role of NOTCH2 in Bladder Cancer and Its Implications for Targeted Therapy.
Clin Cancer Res. 2016 Jan 14. [Epub ahead of print]
7. Kawano Y, Takahashi W, Eto M, Kamba T, Miyake H, Fujisawa M, Kamai T, Uemura H, Tsukamoto T, Azuma H, Matsubara A, Nishimura K, Nakamura T, Ogawa O, Naito S.
Prognosis of metastatic renal cell carcinoma with first-line Interferon-α therapy in the era of molecular-targeted therapy.
Cancer Sci. 2016 Apr 18. doi: 10.1111/cas.12951.
8. Inoue K, Matsuyama H, Fujimoto K, Hirao Y, Watanabe H, Ozono S, Oyama M, Ueno M, Sugimura Y, Shiina H, Mimata H, Azuma H, Nagase Y, Matsubara A, Ito YM, Shuin T.
The clinical trial on the safety and effectiveness of the photodynamic diagnosis of non-muscle-invasive bladder cancer using fluorescent light-guided cystoscopy after oral administration of 5-aminolevulinic acid (5-ALA).
Photodiagnosis Photodyn Ther. 2016 Mar;13:91-6. doi: 10.1016/j.
9. Maeda Y, Goto K, Honda Y, Kuroda N, Sentani K, Yasui W, Hayashi T, Teishima J, Matsubara A, Nakamura Y, Toyota N, Iida M, Awai K.
A case of tubulocystic carcinoma of the kidney with aggressive features.
Jpn J Radiol. 2016 Apr;34(4):307-11. doi: 10.1007/s11604-016-0525-7.
10. Teishima J, Hattori M, Inoue S, Hieda K, Kobatake K, Shinmei S, Egi H, Ohdan H, Matsubara A.
Effect of Spatial Cognitive Ability on Gain in Robot-Assisted Surgical Skills of Urological Surgeons.
J Surg Educ. 2016 Jul-Aug;73(4):624-30. doi: 10.1016/j.jsurg.2016.02.009.
11. Inoue S, Kajiwara M, Teishima J, Matsubara A.
Needlescopic-assisted laparoendoscopic single-site adrenalectomy.
Asian J Surg. 2016 Jan;39(1):6-11. doi: 10.1016/j.asjsur.2015.02.004. Epub 2015 Apr 23.
12. Goto K, Ishikawa S, Honma R, Tanimoto K, Sakamoto N, Sentani K, Oue N, Teishima J, Matsubara A, Yasui W.
The transcribed-ultraconserved regions in prostate and gastric cancer: DNA hypermethylation and microRNA-associated regulation.
Oncogene. 2016 Jul 7;35(27):3598-606. doi: 10.1038/onc.2015.445.
13. Matsubara A.
IJU this issue.
Int J Urol. 2016 Apr;23(4):283. doi: 10.1111/iju.13075.
国内
18. 馬場崎隆志、井上省吾、小畠浩平、重松慶紀、関野陽平、北野弘之、永松弘孝、稗田圭介、郷力昭宏、正路晃一、林 哲太郎、梶原 充、亭島 淳、松原昭郎
低強度体外衝撃波によるED治療効果の検討－陰茎プレチスモグラフィを用いた客観的評価－.
西日本泌尿器科. 2016,
23. 福島貴郁, 淺野耕助, 藤井照護, 奥谷卓也, 藤井慎介, 瀬野康之
独立行政法人国立病院機構広島西医療センターにおける休日前立腺がん検診の4年間の統計報告.
西日本泌尿器科.2016.78(1)20-24
14. 井上省吾
単孔式腹腔鏡手術の整容性と疼痛.
泌尿器外科、2016,29(11),1619-24
15. 本田有紀子、寺田大晃、海地陽子、中村優子、谷千尋、飯田慎、粟井和夫、定秀孝介、後藤景介、林哲太郎、亭島淳、松原昭郎、小野千秋、三田耕司、森浩希、梶原充
特集 腎・上部尿路疾患のCT・MRI 腎盂・尿管病変.
臨床画像.2016,Jul;107(7):1013-7
16. 林哲太郎、亭島 淳、松原昭郎
特集：泌尿器科処方のすべて すぐに使える実践ガイド.腎盂尿管癌.
臨床泌尿器科.2016, 第70巻 第4号（増刊号）, 172-174
17. 林哲太郎、亭島 淳、松原昭郎
特集：泌尿器科処方のすべて すぐに使える実践ガイド.膀胱癌.
臨床泌尿器科. 2016, 第70巻 第4号（増刊号）, 175-178
19. 松原昭郎
特集 意外に知らない？ 泌尿器緩和ケアのすべて 序文.
泌尿器外科.2016,29 (3),205
20. 松原昭郎
特集 泌尿器癌における局所療法の新展開 序文.
泌尿器外科.2016,29 (2),99
21. 永松弘孝、亭島 淳、井上省吾、林哲太郎、松原昭郎
特集：前立腺癌 前立腺癌とメタボリックシンドローム.
日本臨床. 2016, 第74巻・第1号別刷, 149-154
22. 亭島 淳 松原 昭郎
新前立腺癌 最新の基礎研究と診断・治療 前立腺癌の分子生理学と発癌機序 前立腺癌の発癌・進展.
日本臨床.2016,第74巻 増刷号３, 80-86
2015
国際
1. Inoue S, Kajiwara M, Teishima J, Matsubara A.
Population perception of surgical approach in minimally invasive surgery.
Can Urol Assoc J. 2015 Jan-Feb;9(1-2):E1-4. doi: 10.5489/cuaj.2116.
2. Honda Y, Goto K, Sentani K, Yasui W, Ikeda K, Matsubara A, Awai K.
T categorization of urothelial carcinomas of the ureter with CT: preliminary study of new diagnostic criteria proposed for differentiating T2 or lower from T3 or higher.
AJR Am J Roentgenol. 2015 Apr;204(4):792-7. doi: 10.2214/AJR.14.13167.
3. Iwamoto H, Matsuhisa K, Saito A, Kanemoto S, Asada R, Hino K, Takai T, Cui M, Cui X, Kaneko M, Arihiro K, Sugiyama K, Kurisu K, Matsubara A, Imaizumi K.
Promotion of Cancer Cell Proliferation by Cleaved and Secreted Luminal Domains of ER Stress Transducer BBF2H7.
PLoS One. 2015 May 8;10(5):e0125982. doi: 10.1371/journal.pone.0125982.
4. Kanaoka R, Kushiyama A, Seno Y, Nakatsu Y, Matsunaga Y, Fukushima T, Tsuchiya Y, Sakoda H, Fujishiro M, Yamamotoya T, Kamata H, Matsubara A, Asano T.
Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell Lines.
PLoS One. 2015 Jun 3;10(6):e0127467. doi: 10.1371/journal.pone.0127467.
5. Hamasuna R, Yasuda M, Ishikawa K, Uehara S, Hayami H, Takahashi S, Matsumoto T, Yamamoto S, Minamitani S, Watanabe A, Iwata S, Kaku M, Kadota J, Sunakawa K, Sato J, Hanaki H, Tsukamoto T, Kiyota H, Egawa S, Tanaka K, Arakawa S, Fujisawa M, Kumon H, Kobayashi K, Matsubara A, Naito S, Kuroiwa K, Hirayama H, Narita H, Hosobe T, Ito S, Ito K, Kawai S, Ito M, Chokyu H, Matsumura M, Yoshioka M, Uno S, Monden K, Takayama K, Kaji S, Kawahara M, Sumii T, Kadena H, Yamaguchi T, Maeda S, Nishi S, Nishimura H, Shirane T, Yoh M, Akiyama K, Imai T, Kano M.
The second nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan, 2012-2013.
J Infect Chemother. 2015 May;21(5):340-5. doi: 10.1016/j.jiac.2015.01.010.
6. Hayashi T, Seiler R, Oo HZ, Jäger W, Moskalev I, Awrey S, Dejima T, Todenhöfer T, Li N, Fazli L, Matsubara A, Black PC.
Targeting HER2 with T-DM1, an Antibody-cytotoxic Drug Conjugate, is effective in HER2-overexpressing bladder cancer.
J Urol. 2015 Oct;194(4):1120-31. doi: 10.1016/j.juro.2015.05.087.
7. Nagamatsu H, Teishima J, Goto K, Shikuma H, Kitano H, Shoji K, Inoue S, Matsubara A.
FGF19 promotes progression of prostate cancer.
Prostate. 2015 Jul 1;75(10):1092-101. doi: 10.1002/pros.22994.
8. Jang HS, Cho KH, Hieda K, Kim JH, Murakami G, Abe S, Matsubara A.
Composite nerve fibers in the hypogastric and pelvic splanchnic nerves: an immunohistochemical study using elderly cadavers.
Anat Cell Biol. 2015 Jun;48(2):114-23. doi: 10.5115/acb.2015.48.2.114.
9. Ishikawa K, Hamasuna R, Uehara S, Yasuda M, Yamamoto S, Hayami H, Takahashi S, Matsumoto T, Minamitani S, Kadota J, Iwata S, Kaku M, Watanabe A, Sunakawa K, Sato J, Hanaki H, Tsukamoto T, Kiyota H, Egawa S, Deguchi T, Matsumoto M, Tanaka K, Arakawa S, Fujisawa M, Kumon H, Kobayashi K, Matsubara A, Wakeda H, Amemoto Y, Onodera S, Goto H, Komeda H, Yamashita M, Takenaka T, Fujimoto Y, Tsugawa M, Takahashi Y, Maeda H, Onishi H, Ishitoya S, Nishimura K, Mitsumori K, Ito T, Togo Y, Nakamura I, Ito N, Kanamaru S, Hirose T, Muranaka T, Yamada D, Ishihara S, Oka H, Inatomi H, Matsui T, Kobuke M, Kunishima Y, Kimura T, Ichikawa T, Kagara I, Matsukawa M, Takahashi K, Mita K, Kato M, Okumura K, Kawanishi H, Hashimura T, Aoyama T, Shigeta M, Koda S, Taguchi K, Matsuda Y.
Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases.
J Infect Chemother. 2015 Sep;21(9):623-33. doi: 10.1016/j.jiac.2015.05.014.
10. Teishima J, Kobatake K, Kitano H, Nagamatsu H, Sadahide K, Hieda K, Shinmei S, Shoji K, Inoue S, Hayashi T, Inoue Y, Ohara S, Mita K, Matsubara A.
The impact of change in serum C-reactive protein level on the prediction of effects of molecular targeted therapy in patients with metastatic renal cell carcinoma.
BJU Int. 2015 Aug 25. doi: 10.1111/bju.13260.
11. Eto M, Kawano Y, Hirao Y, Mita K, Arai Y, Tsukamoto T, Hashine K, Matsubara A, Fujioka T, Kimura G, Shinohara N, Tatsugami K, Hinotsu S, Naito S; Japan RCC Trialist Collaborative Group (JRTCG) investigators.
Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan.
BMC Cancer. 2015 Oct 9;15:667. doi: 10.1186/s12885-015-1675-1.
12. Matsubara A.
IJU this issue.
Int J Urol. 2015 Sep;22(9):805. doi: 10.1111/iju.12895.
国内
16. 井上省吾, 宮本克利, 松原昭郎.
ヒトCD133陽性細胞移植による新たな陰茎海綿体神経再生-前立腺全摘除術後における勃起不全治療への応用-.
泌尿器外科. 2015, 28(8), 1307-1311
17. 郷力昭宏, 馬場崎 隆志, 小畠浩平, 重松慶紀, 関野陽平, 北野弘之, 後藤景介, 永松弘孝, 稗田圭介, 正路晃一, 井上省吾, 梶原 充, 亭島 淳, 松原昭郎. 1345-1347
ハイリスク前立腺癌における術後PSA再発の予測因子.
泌尿器外科. 2015, 28(8)
18. 井上省吾、梶原充、馬場﨑隆志、小畠浩平、北野弘之、永松弘孝、稗田圭介、正路晃一、林哲太郎、亭島淳、松原昭郎.
単孔式腹腔鏡下副腎摘除術における整容性の縦断的解析.
西日本泌尿器科, 2015, 第77巻第11号, 391-397
19. 梶原 充, 増本 弘史, 井上 省吾, 稗田 圭介, 正路 晃一, 宮本 克利, 小林 加直, 亭島 淳, 松原 昭郎, 浅野 耕助, 奥谷 卓也．
当院泌尿器科における膀胱腟瘻の臨床的検討．
西日本泌尿器科, 2015, 77巻3号, 83-87
13. 亭島 淳.
腎癌に対する腎部分切除術.
西日本泌尿器科. 2015, 第77巻第2号, 43-51
14. 亭島 淳.
新時代の手術 ロボット支援根治的膀胱全摘除術,
泌尿器外科. 2015, 28(3), 281-285
15. 亭島 淳, 稗田圭介, 井上省吾, 小畠浩平, 神明俊輔, 松原昭郎.
ロボット時代の泌尿器科手術①-前立腺癌に対する新たなスタンダード Ⅱ.手術成績 性機能.
臨床泌尿器科. 2015, 第69巻第10号, 862-868
20. 梶原 充.
Trends in Urology; 学童期切迫性尿失禁は中高年期以降の過活動膀胱の独立した危険因子である.
LUTS PIAZZ. Vol.2 No.2.2015
2014
国際
1. Yasuda M, Nakane K, Yamada Y, Matsumoto M, Sho T, Matsumoto M, Kobayashi K, Shigemura K, Nakano Y, Tanaka K, Hamasuna R, Ishihara S, Arakawa S, Yamamoto S, Matsubara A, Fujisawa M, Deguchi T, Matsumoto T.
Clinical effectiveness and safety of tazobactam/piperacillin 4.5 g for the prevention of febrile infectious complication after prostate biopsy.
J Infect Chemother 2014 Oct;20(10): 631-4.
2. Inoue S, Ikeda K, Kobayashi K, Kajiwara M, Teishima J, Matsubara A.
Patient-reported satisfaction and cosmesis outcomes following laparoscopic adrenalectomy: Laparoendoscopic single-site adrenalectomy vs. conventional laparoscopic adrenalectomy.
Can Urol Assoc J. 2014 Jan-Feb;8(1-2):E20-5. doi: 10.5489/cuaj.1543.
3. Teishima J, Hattori M, Matsubara A.
Psychological factor, metacognition, is associated with the advantage of suturing techniques acquired on a virtual reality simulator of robot-assisted surgery.
Int J Urol. 2014 Mar;21(3):349-50. doi: 10.1111/iju.12286.
4. Teishima J, Yano S, Shoji K, Hayashi T, Goto K, Kitano H, Oka K, Nagamatsu H, Matsubara A.
Accumulation of FGF9 in prostate cancer correlates with epithelial-to-mesenchymal transition and induction of VEGF-A expression.
Anticancer Res. 2014 Feb;34(2):695-700.
5. Miyamoto K, Inoue S, Kobayashi K, Kajiwara M, Teishima J, Matsubara A.
Rat cavernous nerve reconstruction with CD133+ cells derived from human bone marrow.
J Sex Med. 2014 May;11(5):1148-58. doi: 10.1111/jsm.12485.
6. Hamasuna R, Tanaka K, Hayami H, Yasuda M, Takahashi S, Kobayashi K, Kiyota H, Yamamoto S, Arakawa S, Matsumoto T; Japanese Research Group for UTI (JRGU).
Treatment of acute uncomplicated cystitis with faropenem for 3 days versus 7 days: multicentre, randomized, open-label, controlled trial.
J Antimicrob Chemother. 2014 Jun;69(6):1675-80. doi: 10.1093/jac/dku014.
7. Kamiya N, Suzuki H, Nishimura K, Fujii M, Okegawa T, Matsuda T, Morita T, Takihana Y, Ozono S, Namiki M, Matsubara A, Ichikawa T, Miki T.
Development of nomogram to non-steroidal antiandrogen sequential alternation in prostate cancer for predictive model.
Jpn J Clin Oncol. 2014 Mar;44(3):263-9. doi: 10.1093/jjco/hyt230.
8. Togo Y, Kubo T, Taoka R, Hiyama Y, Uehara T, Hashimoto J, Kurimura Y, Takahashi S, Tsukamoto T, Miyazaki J, Nishiyama H, Kira S, Kiyota H, Yazawa S, Niwa N, Hongo H, Oya M, Kato T, Yasuda M, Deguchi T, Ishikawa K, Hoshinaga K, Matsumoto M, Shigemura K, Tanaka K, Arakawa S, Fujisawa M, Wada K, Uehara S, Watanabe T, Kumon H, Kobayashi K, Matsubara A, Matsumoto M, Sho T, Hamasuna R, Matsumoto T, Hayami H, Nakagawa M, Yamamoto S.
Occurrence of infection following prostate biopsy procedures in Japan: Japanese Research Group for Urinary Tract Infection (JRGU) – a multi-center retrospective study.
J Infect Chemother. 2014 Apr;20(4):232-7. doi: 10.1016/j.jiac.2013.10.003.
9. Hinata N, Hieda K, Sasaki H, Murakami G, Abe S, Matsubara A, Miyake H, Fujisawa M.
Topohistology of sympathetic and parasympathetic nerve fibers in branches of the pelvic plexus: an immunohistochemical study using donated elderly cadavers.
Anat Cell Biol. 2014 Mar;47(1):55-65. doi: 10.5115/acb.2014.47.1.55.
10. Hinata N, Hieda K, Sasaki H, Kurokawa T, Miyake H, Fujisawa M, Murakami G, Fujimiya M.
Nerves and fasciae in and around the paracolpium or paravaginal tissue: an immunohistochemical study using elderly donated cadavers.
Anat Cell Biol. 2014 Mar;47(1):44-54. doi: 10.5115/acb.2014.47.1.44.
11. Goriki A, Hatanaka F, Myung J, Kim JK, Yoritaka T, Tanoue S, Abe T, Kiyonari H, Fujimoto K, Kato Y, Todo T, Matsubara A, Forger D, Takumi T.
A novel protein, CHRONO, functions as a core component of the mammalian circadian clock.
PLoS Biol. 2014 Apr 15;12(4):e1001839. doi: 10.1371/journal.pbio.1001839.
12. Hwang SE, Hieda K, Kim JH, Murakami G, Abe S, Matsubara A, Cho BH.
Region-specific differences in the human myenteric plexus: an immunohistochemical study using donated elderly cadavers.
Int J Colorectal Dis. 2014 Jul;29(7):783-91. doi: 10.1007/s00384-014-1869-z.
13. Shoji K, Teishima J, Hayashi T, Ohara S, Mckeehan WL, Matsubara A.
Restoration of fibroblast growth factor receptor 2IIIb enhances the chemosensitivity of human prostate cancer cells.
Oncol Rep. 2014 Jul;32(1):65-70. doi: 10.3892/or.2014.3200.
14. Kajiwara M, Inoue S, Kobayashi K, Ohara S, Teishima J, Matsubara A.
Therapeutic efficacy of narrow band imaging-assisted transurethral electrocoagulation for ulcer-type interstitial cystitis/painful bladder syndrome.
Int J Urol. 2014 Apr;21 Suppl 1:57-60. doi: 10.1111/iju.12350.
15. Teishima J, Kobatake K, Hayashi T, Seno Y, Ikeda K, Nagamatsu H, Hieda K, Shoji K, Miyamoto K, Inoue S, Kobayashi K, Ohara S, Kajiwara M, Matsubara A.
Prognostic significance of C-reactive protein in patients with intermediate-risk metastatic renal cell carcinoma treated with molecular targeted therapy.
Oncol Lett. 2014 Aug;8(2):881-885.
16. Teishima J, Maruyama S, Mochizuki H, Oka K, Ikeda K, Goto K, Nagamatsu H, Hieda K, Shoji K, Matsubara A.
Prostate cancer detection by prostate-specific antigen-based screening in the Japanese Hiroshima area shows early stage, low-grade, and low rate of cancer-specific death compared with clinical detection.
Can Urol Assoc J. 2014 May;8(5-6):E327-32. doi: 10.5489/cuaj.1715.
17. Teishima J, Hieda K, Inoue S, Goto K, Ikeda K, Ohara S, Kobayashi K, Kajiwara M, Matsubara A.
Comparison of initial experiences of robot-assisted radical cystectomy with those of laparoscopic for bladder cancer.
Innovations (Phila). 2014 Jul-Aug;9(4):322-6. doi: 10.1097/IMI.0000000000000056.
18. Teishima J, Hattori M, Inoue S, Hieda K, Ohara S, Egi H, Ohdan H, Matsubara A.
Retention of robot-assisted surgical skills in urological surgeons acquired using Mimic dV-Trainer.
Can Urol Assoc J. 2014 Jul;8(7-8):E493-7. doi: 10.5489/cuaj.1993.
19. Shinmei S, Sentani K, Hayashi T, Sakamoto N, Goto K, Zarni Oo H, Naito Y, Teishima J, Matsubara A, Oue N, Kuniyasu H, Yasui W.
Identification of PRL1 as a novel diagnostic and therapeutic target for castration-resistant prostate cancer by the Escherichia coli ampicillin secretion trap (CAST) method.
Urol Oncol. 2014 Aug;32(6):769-78. doi: 10.1016/j.urolonc.2014.03.007.
20. Goto K, Oue N, Hayashi T, Shinmei S, Sakamoto N, Sentani K, Teishima J, Matsubara A, Yasui W.
Oligophrenin-1 is associated with cell adhesion and migration in prostate cancer.
Pathobiology. 2014;81(4):190-8. doi: 10.1159/000363345.
21. Inoue S, Ikeda K, Kajiwara M, Teishima J, Matsubara A.
Laparoendoscopic single-site adrenalectomy sans transumbilical approach: initial experience in Japan.
Urol J. 2014 Sep 6;11(4):1772-6.
22. 梶原 充, 稗田圭介, 正路晃一, 宮本克利, 井上省吾, 小林加直, 大原慎也, 亭島 淳, 松原昭郎.
女性の泌尿器科疾患.
産婦人科の実際. 2014 vol.63 No.3:421-426
国内
23. 梶原 充, 増本弘史, 上野剛志, 池田健一郎, 井上省吾, 稗田圭介, 正路晃一, 宮本克利, 小林加直, 亭島 淳, 浅野耕助, 奥谷卓也, 松原昭郎.
当泌尿器科における膀胱腟瘻閉鎖術の3例.
広島医学, 2014, vol.67 No.3: 201-205
24. 井上省吾, 松原昭郎. 特集 前立線癌治療に伴う排尿障害
各種術式の下部尿路症状(LUTS)に及ぼす影響.
排尿障害プラクティス. 2014 vol.22 No.1: 15-22
34. 亭島 淳, 池田 健一郎, 稗田 圭介, 正路 晃一, 宮本 克利, 井上 省吾, 小林 加直, 大原 慎也, 梶原 充, 松原 昭郎.
淡明細胞癌以外の成分を含む転移性腎細胞癌の検討.
泌尿器外科, 2014, 27巻別冊号, 53-55
35. 梶原 充, 稗田 圭介, 正路 晃一, 宮本 克利, 井上 省吾, 小林 加直, 大原 慎也, 亭島 淳, 松原 昭郎.
わが国小学生を対象にした睡眠と夜尿症に関するインターネットリサーチを用いた大規模疫学調査,
夜尿症研究, 2014, 19巻, 31-35.
36. 和田耕一郎,谷本 竜太,能勢 宏幸,上原 慎也,渡辺 豊彦,速見 浩士,永井 真吾,安田 満,出口 隆,茂田 啓介,矢澤 聰,菊地 栄次,大家 基嗣,橋本 次朗,上原 央久,栗村雄一郎,桧山 佳樹,高橋 聡,,塚本 泰司,庄 武彦,濵砂 良一,宮崎 淳,東郷 容和,田岡利宜也,中尾 篤,山本 新吾,小林 加直,松原 昭郎,石川 清仁,公文 裕巳,松本 哲朗.
泌尿器科領域における抗癌化学療法に伴う発熱性好中球減少症に関する多施設共同調査.
日本化学療法学会雑誌,2014,62(3),374-381.
25. 亭島 淳.
前立線癌の診療ナビゲーション-分かりやすく丁寧に！Ⅲ.前立線癌の病期(ステージ)分類とリスク分類 NCCNのリスク分類.
臨床泌尿器科. 2014 68(4)増刊号: 98-102
26. 亭島 淳.
前立線癌の診療ナビゲーション-分かりやすく丁寧に！Ⅳ.経会陰式前立腺全摘除術の実際と問題点.
臨床泌尿器科. 2014 68(5)増刊号: 122-126
27. 亭島 淳, 妹尾安子, 松原昭郎.
ロボット支援手術におけるチーム医療.
Japanese Journal of Endourology. 2014 Vol.27 No.1: 121-123
28. 井上省吾, 松原昭郎.
患者さんへの説明にそのまま使える！泌尿器科手術のすべて 第3章4.根治的前立腺全摘除術.
泌尿器ケア. 2014 夏季増刊226号: 153-160
29. 梶原 充, 亭島 淳, 松原昭郎.
シンポジウム1：高齢化社会における泌尿器科の役割：〜今,泌尿器科に求められているもの〜高齢者の排尿の治療.
西日本泌尿器科. 2014 76(7): 218-224
30. 松原昭郎.
第102回日本泌尿器科学会総会印象記.
西日本泌尿器科. 2014, 76巻, 291-292
31. 亭島 淳.
第102回日本泌尿器科学会総会印象記.
臨床泌尿器科. 2014, 第68巻 第10号, 792-793
32. 松原昭郎, 河合憲康.
特集1:ロボット手術-チームで取り組むトラブルシューティング 序文.
Japanese Journal of Endourology, 2014, 27, 229-229
33. 妹尾安子, 亭島 淳, 井上省吾, 稗田圭介, 松原昭郎.
特集1:ロボット手術-チームで取り組むトラブルシューティング 全国アンケート結果.
Japanese Journal of Endourology, 2014, 27, 241-245
2013
国際
1. Hayami H, Takahashi S, Ishikawa K, Yasuda M, Yamamoto S, Uehara S, Hamasuna R, Matsumoto T, Minamitani S, Watanabe A, Iwamoto A, Totsuka K, Kadota J, Sunakawa K, Sato J, Hanaki H, Tsukamoto T, Kiyota H, Egawa S, Tanaka K, Arakawa S, Fujisawa M, Kumon H, Kobayashi K, Matsubara A, Naito S, Tatsugami K, Yamaguchi T, Ito S, Kanokogi M, Narita H, Kawano H, Hosobe T, Takayama K, Sumii T, Fujii A, Sato T, Yamauchi T, Izumitani M, Chokyu H, Ihara H, Akiyama K, Yoshioka M, Uno S, Monden K, Kano M, kaji S, Kawai S, Ito K, Inatomi H, Nishimura H, Ikuyama T, Nishi S, Takahashi K, Kawano Y, Ishihara S, Tsuneyoshi K, Matsushita S, Yamane T, Hirose T, Fujihiro S, Endo K, Oka Y, Takeyama K, Kimura T, Uemura T.
Nationwide surveillance of bacterial pathogens from patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2009 and 2010: antimicrobial susceptibility of Escherichia coli and Staphylococcus saprophyticus.
J Infect Chemother. 2013 Jun;19(3):393-403. doi: 10.1007/s10156-013-0606-9.
2. Goto K, Oue N, Shinmei S, Sentani K, Sakamoto N, Naito Y, Hatasahi T, Teishima J, Matsubara A, Yasui W.
Expression of miR-486 is a potential prognostic factor after nephrectomy in advanced renal cell carcinoma.
Mol Clin Oncol. 2013 Mar;1(2):235-240.
3. Seki M, Teishima J, Mochizuki H, Mutaguchi K, Yasumoto H, Oka K, Nagamatsu H, Shoji K, Matsubara A.
Restoration of IGFBP-rP1 increases radiosensitivity and chemosensitivity in hormone-refractory human prostate cancer.
Hiroshima J Med Sci. 2013 Mar;62(1):13-9.
4. Shinmei S, Sakamoto N, Goto K, Sentani K, Anami K, Hayashi T, Teishima J, Matsubara A, Oue N, Kitadai Y, Yasui W.
MicroRNA-155 is a predictive marker for survival in patients with clear cell renal cell carcinoma.
Int J Urol. 2013 May;20(5):468-77. doi: 10.1111/j.1442-2042.2012.03182.x.
5. Hamasuna R, Yasuda M, Ishikawa K, Uehara S, Takahashi S, Hayami H, Yamamoto S, Matsumoto T, Minamitani S, Watanabe A, Iwamoto A, Totsuka K, Kadota J, Sunakawa K, Sato J, Hanaki H, Tsukamoto T, Kiyota H, Egawa S, Tanaka K, Arakawa S, Fujisawa M, Kumon H, Kobayashi K, Matsubara A, Naito S, Tatsugami K, Ito S, Narita H, Kanokogi M, Sumii T, Ito K, Hosobe T, Kawai S, Kawano H, Takayama K, Yamaguchi T, Endo K, Yamauchi T, Maeda S, Yoh M, Horie M, Ito M, Chokyu H, Ihara H, Akiyama K, Uno S, Monden K, Kaji S, Nishimura H, Kawahara M, Sato T, Konishi T, Nishi S, Ishihara S, Yoshioka M.
Nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan.
J Infect Chemother. 2013 Aug;19(4):571-8. doi: 10.1007/s10156-013-0637-2.
6. Taoka R, Togo Y, Kubo T, Kido M, Miki K, Kiyota H, Egawa S, Sugawara T, Yasuda M, Nakano M, Deguchi T, Nishino M, Ishikawa K, Shiroki R, Matsumoto M, Shigemura K, Tanaka K, Arakawa S, Fujisawa M, Wada K, Watanabe T, Kumon H, Kobayashi K, Matsubara A, Sho T, Hamasuna R, Matsumoto T, Hayami H, Nakagawa M, Yamamoto S.
Assessment of antimicrobial prophylaxis to prevent perioperative infection in patients undergoing prostate brachytherapy: multicenter cohort study.
J Infect Chemother. 2013 Oct;19(5):926-30. doi: 10.1007/s10156-013-0610-0.
7. Hayashi T, Sentani K, Oue N, Ohara S, Teishima J, Anami K, Sakamoto N, Matsubara A, Yasui W.
The search for secreted proteins in prostate cancer by the Escherichia coli ampicillin secretion trap: expression of NBL1 is highly restricted to the prostate and is related to cancer progression.
Pathobiology. 2013;80(2):60-9. doi: 10.1159/000341396.
8. Kobayashi K, Hayashi I, Kouda S, Kato F, Fujiwara T, Kayama S, Hirakawa H, Itaha H, Ohge H, Gotoh N, Usui T, Matsubara A, Sugai M.
Identification and characterization of a novel aac(6′)-Iag associated with the blaIMP-1-integron in a multidrug-resistant Pseudomonas aeruginosa.
PLoS One. 2013 Aug 12;8(8):e70557. doi: 10.1371/journal.pone.0070557.
9. Hieda K, Hayashi S, Kim JH, Murakami G, Cho BH, Matsubara A.
Spatial relationship between expression of cytokeratin-19 and that of connexin-43 in human fetal kidney.
Anat Cell Biol. 2013 Mar;46(1):32-8. doi: 10.5115/acb.2013.46.1.32.
10. Hieda K, Cho KH, Arakawa T, Fujimiya M, Murakami G, Matsubara A.
Nerves in the intersphincteric space of the human anal canal with special reference to their continuation to the enteric nerve plexus of the rectum.
Clin Anat. 2013 Oct;26(7):843-54. doi: 10.1002/ca.22227.
11. Eto M, Kamba T, Miyake H, Fujisawa M, Kamai T, Uemura H, Tsukamoto T, Azuma H, Matsubara A, Nishimura K, Nakamura T, Ogawa O, Naito S; Japan Immunotherapy SNPs-Study Group for Kidney Cancer.
STAT3 polymorphism can predict the response to interferon-α therapy in patients with metastatic renal cell carcinoma.
Eur Urol. 2013 Apr;63(4):745-52. doi: 10.1016/j.eururo.2012.09.052.
12. Inoue S, Shiina H, Mitsui Y, Yasumoto H, Matsubara A, Igawa M.
Identification of lymphatic pathway involved in the spread of bladder cancer: Evidence obtained from fluorescence navigation with intraoperatively injected indocyanine green.
Can Urol Assoc J. 2013 May-Jun;7(5-6):E322-8. doi: 10.5489/cuaj.12096.
13. Ishizuka, Osamu; Matsuyama, Hideyasu; Sakai, Hideki; Matsubara, Akio; Nagaoka, Akira; Takahashi, Satoru; Takeda, Masayuki; Ozono, Seiichiro; Shiroki, Ryoichi; Shuin, Taro; Hara, Isao; Kakizaki, Hidehiro; Tsukamoto, Taiji; Yamanishi, Tomonori; Yokoyama, Osamu; Kakehi, Yoshiyuki; Nishizawa, Osamu.
Nocturia Potentially Influences Maintenance of Sexual Function in Elderly Men with Benign Prostatic Hyperplasia.
LUTS-LOWER URINARY TRACT SYMPTOMS. 2013 5(2):75-81.
国内
14. 北野弘之, 牟田口和昭, 郷力昭宏, 神明俊輔, 岩本秀雄, 林哲太郎.
筋層非浸潤性膀胱癌(Ta、T1) に対するBCG膀胱腔内注入療法の治療成績とEAUガイドラインのリスク分類の検討.
西日本泌尿器科. 2013, 75巻3号:107-113
15. 東郷容和, 田岡利宣也, 山本新吾, 桧山佳樹, 上原央久, 橋本次朗, 栗村雄一郎, 高橋聡, 塚本泰司, 宮崎淳, 西山博之, 清田 浩, 矢沢 聰, 大家基嗣, 安田 満, 出口 隆, 石川清仁, 星長清隆, 松本 穣, 重村克巳, 田中一志, 荒川創一, 藤澤正人, 和田耕一郎, 上原慎也, 渡辺豊彦, 公文裕巳, 小林加直, 松原昭郎, 松本正広, 庄 武彦, 濱砂良一, 松本哲朗, 速見浩士, 山根隆史, 中川昌之.
泌尿器科領域における周術期感染症予防抗菌薬の使用状況についてのアンケート調査報告.
日本泌尿器科学会雑誌, 2013, 104(4):579-588
21. 梶原 充, 井上省吾, 増本弘史, 上野剛志, 池田 健一郎, 稗田圭介, 正路晃一, 宮本克利, 小林加直, 大原慎也, 亭島 淳, 松原昭郎.
当院における上部尿路腫瘍に対する経尿道的内視鏡的治療の初期経験.
広島医学, 2013, vol.66 No.8: 491-495
22. 梶原 充, 沖 真実, 宮本克利, 井上省吾, 小林加直, 亭島 淳, 松原昭郎.
広島県における泌尿器科医・非泌尿器科医の過活動膀胱診療・治療の実態調査. 広島大学
泌尿器外科. 2013, 26（4）: 483-488
25. 亭島 淳, 瀬野康之, 池田健一郎, 稗田圭介, 正路晃一, 宮本克利, 井上省吾, 小林加直, 梶原 充, 松原昭郎.
転移性腎細胞癌に対する分子標的治療の予後予測．
泌尿器外科. 2013, 26（Suppl): 14-16
26. 梶原 充, 宮本 克利, 増本弘史, 北野弘之, 池田健一郎, 稗田圭介, 正路晃一, 井上省吾, 小林加直, 大原慎也, 亭島 淳, 松原昭郎.
間質性膀胱炎：小児例は存在するのか.
排尿障害プラクティス. 2013, vol.21No.3, 32-37
27. 柴田昌紀, 後藤景介, 林哲太郎, 池田健一郎, 稗田圭介, 正路晃一, 宮本克利, 増本弘史, 井上省吾, 小林加直, 梶原充, 松原昭郎.
転移性腎細胞癌に対するエベロリムス投与後に急性腎不全を来たした1例.
西日本泌尿器科. 2013, 75巻7号:383 -389
16. 亭島 淳.
腹部腫瘤, 泌尿器科診療ベストNAVI 症状・兆候からのアプローチ
腫瘤, 2013, 67(4): 50-51
17. 亭島 淳,
陰囊内腫瘤, 泌尿器科診療ベストNAVI 症状・兆候からのアプローチ
腫瘤, 2013, 67(4): 52-53
18. 亭島 淳.
腎疾患に対する薬剤の使用方法
腎尿路系悪性腫瘍, 腎疾患マニュアル, 2013, 増刊号: 324-327
19. 井上省吾, 亭島 淳, 松原昭郎.
連載 泌尿器科領域におけるトラブルシューティング 腹腔鏡か前立腺全摘除術における膀胱尿道吻合時損傷した縫合針が肛門挙筋に迷入し摘出に難渋した経験.
泌尿器外科. 2013, 26(4), 451-453
20. 亭島 淳, 松原昭郎.
ロボット支援腎部分切除術ー経腹膜アプローチ.
Japanese Juornal of Endourology. 2013, 26: 7-12
23. 梶原 充.
様々な可能性を持った医療機器検査環境の改善に期待.
TOTOフロースカイ導入事例集. 2013, 3: 4-7
24. 亭島 淳, 奥谷卓也.
腎癌の治療ー最近の展開ー.
PHYSICIANS’ THERAPY MANUAL. 2013, 6(1),
28. 井上 省吾, 梶原 充, 亭島 淳, 松原 昭郎.
【泌尿器疾患に対する単孔式腹腔鏡手術】 腎腫瘍に対する経腹膜的単孔式腹腔鏡手術,
Japanese Journal of Endourology, 2013, 26巻1号, 62-67
29. 井上 省吾, 亭島 淳, 松原 昭郎.
【泌尿器科手術1】 泌尿器科腹腔鏡下手術の最新事情 単孔式手術やロボット支援手術が急速に普及中.
LiSA, 2013, 20巻5号, 482-485
2012
国際
1. Teishima J, Iwamoto H, Miyamoto K, Shoji K, Masumoto H, Inoue S, Kobayashi K, Kajiwara M, Matsubara A.
Impact of pre-implant lower urinary tract symptoms on postoperative urinary morbidity after permanent prostate brachytherapy.
Int J Urol. 2012 Dec;19(12):1083-9. doi: 10.1111/j.1442-2042.2012.03105.x.
2. Teishima J, Hattori M, Inoue S, Ikeda K, Hieda K, Miyamoto K, Shoji K, Hayashi T, Kobayashi K, Kajiwara M, Egi H, Ohdan H, Matsubara A.
Impact of laparoscopic experience on the proficiency gain of urologic surgeons in robot-assisted surgery.
J Endourol. 2012 Dec;26(12):1635-8. doi: 10.1089/end.2012.0308.
3. Teishima J, Shoji K, Hayashi T, Miyamoto K, Ohara S, Matsubara A.
Relationship between the localization of fibroblast growth factor 9 in prostate cancer cells and postoperative recurrence.
Prostate Cancer Prostatic Dis. 2012 Mar;15(1):8-14. doi: 10.1038/pcan.2011.48.
4. Miyamoto K, Inoue S, Kajiwara M,Teishima J, Matsubara A.
Comparison of renal function after partial nephrectomy and radical nephrectomy for renal cell carcinoma.
Urol Int. 2012;89(2):227-32. doi: 10.1159/000339969.
5. Masumoto H, Takenaka A, Rodríguez-Vázquez JF, Murakami G, Matsubara A.
Reappraisal of intergender differences in the urethral striated sphincter explains why a completely circular arrangement is difficult in females: a histological study using human fetuses.
Anat Cell Biol. 2012 Jun;45(2):79-85. doi: 10.5115/acb.2012.45.2.79.
国内
9. 神明俊輔、高広悠平、柴田昌紀、瀬野康之、金岡隆平、稗田圭介、正路晃一、宮本克利、増本弘史、井上省吾、小林加直、林哲太郎、梶原充、亭島淳、松原昭 郎.
腹腔鏡下前立腺全摘除術における膀胱尿道吻合のV-Loc™180の使用経験.
西日本泌尿器科, 2012, 74(12): 682－685.
10. 亭島 淳、池田健一郎、瀬野康之、小林加直、林 哲太郎、松原昭郎、小畠浩平・三田耕司、永松弘孝、藤原政治、角西雄一、中原 満、高広悠平、小深田義勝、上田晃嗣、長谷川泰久、水谷雅巳、吉野干城、森山浩之、望月英樹.
進行性腎細胞癌に対する薬物療法 ―ファーストラインの分子―標的薬―.
西日本泌尿器科, 2012, 24(11): 251－258.
11. 梶原 充, 池田 健一郎, 岩本秀雄, 瀬野康之, 増本弘史, 小畠浩平, 郷力昭宏, 金岡隆平, 神明俊輔, 沖 真実, 正路晃一, 宮本克利, 井上省吾, 林 哲太郎, 小林加直, 亭島 淳, 松原昭郎.
腎細胞癌に対する単孔式腹腔鏡下根治的腎摘除術の安全性、有用性の検討 初期3例報告.
広島医学, 2012, 64(11): 489－493.
12. 梶原 充、増本弘史、池田健一郎、井上省吾、柴田昌紀、稗田圭介、正路晃一、宮本克利、小林加直、林 哲太郎、亭島 淳、松原昭郎.
肝拳上用ポートを追加増設することなく Laparo-Endoscopic Single-Site Surgeryで右腎摘除術を行った3例.
広島医学, 2012, 65(9): 616－620.
13. 亭島 淳、柴田昌紀、池田健一郎、稗田圭介、正路晃一、宮本克利、増本弘史、井上省吾、小林加直、林哲太郎、梶原 充、松原昭郎. 25(8): 1655－1658.
低・中リスク群限局性前立腺癌に対する密封小線源永久挿入治療の治療成績.
泌尿器外科, 2012,
14. 小林加直, 柴田昌紀, 池田健一郎, 稗田圭介, 正路晃一, 宮本克利, 増本弘史, 井上省吾, 林 哲太郎, 梶原 充, 亭島 淳, 松原昭郎.
高齢者の筋層非浸潤性膀胱癌に対するBCG膀胱内注入療法の有効性と安全性.
泌尿器外科, 2012, 25(4): 753－754.
15. 亭島 淳、井上省吾、稗田圭介、柴田昌紀、池田健一郎、正路晃一、宮本克利、増本弘史、小林加直、林哲太郎、梶原 充、松原昭郎.
ロボット支援根治的膀胱全摘除術の初期経験.
Jpn J Endourol, 2012, 25(2): 332－336.
25. 梶原 充, 金岡 隆平, 井上 省吾, 林 哲太郎, 亭島 淳, 松原 昭郎. 他10名 ： Page142-143(2012.02)
骨盤臓器脱のひとつ腟断端脱に対する経腟式メッシュ手術(total-TVM;Tension-free-Vaginal Mesh)の安全性と有用性.
広島医学 (0367-5904)65巻2号
27. 梶原 充, 金岡 隆平, 正路 晃一, 井上 省吾, 林 哲太郎, 亭島 淳, 松原 昭郎. 他9名 ： (0367-5904)65巻2号 Page142(2012.02)
女性腹圧性尿失禁に対する経閉鎖孔式中部尿道スリング手術(TVT-OT;Tension-free-Vaginal Tape-Transobturator tape)の安全性と有用性.
広島医学
6. 松原昭郎.
広大病院など導入 内視鏡手術ロボ4月から保険適用へ.
中国新聞, 2012.2.15朝刊.
7. Patrick C.Walsh, MD. Radical Retropublic and Perineal Prostatectomy CAMPBELL-WALSH UROLOGY TENTH EDITION Chapter102. 監修:松原昭郎,
恥骨後式および会陰式前立腺全摘除術,
CAMPBELL-WALSH UROLOGY, 第10版, 102章
8. Radical Retropubic and Perineal Prostatectomy CAMPBELL-WALSH UROLOGY TENTH EDITION Capter102. 日本語要約:松原昭郎,
恥骨後式および会陰式前立腺全摘除術,
CAMPBELL-WALSH UROLOGY, 第10版, 102章:1-3.
16. 梶原 充.
腎の炎症性疾患.
泌尿器科診療ガイド, 2012: 107－109.
17. 梶原 充、増本弘史、井上省吾、柴田昌紀、池田健一郎、稗田圭介、正路晃一、宮本克利、小林加直、林 哲太郎、亭島 淳、松原昭郎.
肉眼的血尿をきたす薬剤.
臨床泌尿器科, 2012, 66(8): 541－545.
18. 亭島 淳.
副作用の予防法と発症時の対応：口内炎、味覚障害、腎機能障害.
泌尿器ケア, 2012, 17(9): 80－82.
19. 梶原 充、小林加直、沖 真実、岩本秀雄、小畠浩平、郷力昭宏、正路晃一、宮本克利、増本弘史、井上省吾、亭島 淳、松原昭郎.
膀胱癌の新しい内視鏡的診断ツール －i-scan, narrow band image－.
広島医学別冊, 2012, 65(5): 355－356.
20. 亭島 淳、松原昭郎.
手術手技：指導的助手からみた泌尿器科手術のポイント9 恥骨後式前立腺全摘除術（解説）
臨床泌尿器科, 2012, 66(2): 115－121.
21. 梶原 充.
第11章小児泌尿器科：小児の下部尿路症状の診断と治療 Ⅳ小児の下部尿路症状の治療.
日本泌尿器科学会 2012年卒後教育テキスト, 2012, 17(1): 233－237.
22. 梶原 充、亭島 淳、松原昭郎.
過活動膀胱 Overactive bladder. 腎と透析:
増刊号腎疾患治療マニュアル2012, Vol.72, 573－576.
23. 梶原 充.
さっき行ったのに・・・また？それは「過活動膀胱」かも.
リビングひろしま, 2012.1.28(1488号) 1－2.
24. 井上省吾.
後腹膜腫瘍，後腹膜線維症.
今日の治療指針, 2012, 944－945.
26. 亭島 淳.
【泌尿器科ベッドサイドマニュアル】 全身合併症を有する患者の管理 脳血管障害の既往を有する患者の管理.
臨床泌尿器科.2012.66(4)300-303.
2011
国際
1. Hayashi T, Oue N, Sakamoto N, Anami K, Oo HZ, Sentani K, Ohara S, Teishima J, Matsubara A, Yasui W.
Identification of transmembrane protein in prostate cancer by the Escherichia coli ampicillin secretion trap: expression of CDON is involved in tumor cell growth and invasion.
Pathobiology. 2011;78(5):277-84. doi: 10.1159/000329588.
2. Hayashi T, Sentani K, Oue N, Anami K, Sakamoto N, Ohara S, Teishima J, Noguchi T, Nakayama H, Taniyama K, Matsubara A, Yasui W.
Desmocollin 2 is a new immunohistochemical marker indicative of squamous differentiation in urothelial carcinoma.
Histopathology. 2011 Oct;59(4):710-21. doi: 10.1111/j.1365-2559.2011.03988.x.
3. Inoue S, Shiina H, Arichi N, Mitsui Y, Hiraoka T, Wake K, Sumura M, Honda S, Yasumoto H, Urakami S, Matsubara A, Igawa M.
Identification of lymphatic pathway involved in the spreading of prostate cancer by fluorescence navigation approach with intraoperatively injected indocyanine green.
Can Urol Assoc J. 2011 Aug;5(4):254-9. doi: 10.5489/cuaj.10159.
4. Teishima J, Kenjo M, Kobatake K, Iwamoto H, Goriki A, Oki M, Shoji K, Miyamoto K, Masumoto H, Inoue S, Kobayashi K, Ohara S, Kajiwara M, Kimura T, Murakami Y, Kaneyasu Y, Nishibuchi I, Nagata Y, Matsubara A.
Six-year experience of permanent prostate brachytherapy for clinically localized prostate cancer.
Hiroshima J Med Sci. 2011 Sep;60(3):51-6.
5. Masumoto H, Rodríguez-Vázquez JF, Verdugo-López S, Murakami G, Matsubara A.
Fetal topographical anatomy of the female urethra and descending vagina: a histological study of the early human fetal urethra.
Ann Anat. 2011 Dec 20;193(6):500-8. doi: 10.1016/j.aanat.2011.03.010.
6. Hasegawa Y, Mita K, Ueki T, Ishida Y, Koda S, Seno Y, Nakamoto T, Matsubara A,
Retroperitoneoscopic treatment of ureteral invagination caused by a long fibroepithelial polyp protruding into the bladder: Report of a case.
Surg Today 2011 41 1117-21
国内
8. 梶原充，池田健一郎，岩本秀雄, 瀬野康之，増本弘史，小畠浩平，郷力昭宏，金岡隆平，神明俊輔，沖真実，正路晃一，宮本克利，井上省吾，林哲太郎，小林加直，亭島淳，松原昭郎.
腎細胞癌に対する単孔式腹腔鏡下根治的腎摘除術の安全性，有用性の検討，初期3例報告,
広島医学, 2011, 64(11), 489-493
16. 亭島淳，高広悠平，小畠浩平，岩本秀雄，郷力昭宏，沖真実，正路晃一，宮本克利，増本弘史，井上省吾，大原慎也，小林加直，梶原充，松原昭郎.
有害事象によりチロシンキナーゼ阻害剤投与の中止を余儀なくされた腎癌症例の検討,
腎癌研究会会報, 2011, 41(9) , 65-67
17. 亭島淳，小畠浩平，高広悠平，岩本秀雄，郷力昭宏，沖 真実，正路晃一，宮本克利，増本弘史，井上省吾，小林加直，大原慎也，梶原 充，松原昭郎.
去勢抵抗性前立腺癌に対するドセタキセル・エストラムスチン併用療法の治療成績,
泌尿器外科, 2011, 24((8) , 1355-1357
21. 宮本克利 ，小林加直，小畠浩平，岩本秀雄，郷力昭宏 ，沖真実，正路晃一，増本弘史 ，井上省吾 ，梶原充 ，亭島淳 ，松原昭郎.
陰茎海綿体膿瘍の１例
西日本泌尿器科, 2011, 73(8) , 426-429
7. 梶原充.
新しい前立腺肥大症診療ガイドラインの読み方 — 快適な排尿ライフのために—,
安芸地区医師会月報, 2011,64 (455)
9. 梶原充，岩本秀雄，正路晃一，増本弘史，井上省吾，桐谷玲子，小林加直，大原慎也，亭島淳，三田耕司，松原昭郎.
SUCCESSFUL SUPERSELECTIVE CAVERNOUS ARTERY EMBOLIZATION WITH MICROCOILS FOR POST-TRAUMATIC NONISCHEMIC PRIAPISM :A CASE REPORT(超選択的動脈塞栓術が有効であった非虚血性持続勃起症の1例)
西日本泌尿器科, 2011, 73(3) , 105-109
10. 梶原充，金岡隆平，神明俊輔，瀬野康之，正路晃一，宮本克利，増本弘史，井上省吾，小林加直，林哲太郎，亭島淳，松原昭郎.
「頻尿・切迫性尿失禁」頻尿患者からどのようにして間質性膀胱炎を診断するか？（解説・特集）,
臨床泌尿器科, 2011, 65(10) , 747-752
11. 梶原充，後藤景介，稗田圭介，金岡隆平，神明俊輔，瀬野康之，正路晃一，沖真美，宮本克利，増本弘史，井上省吾，小林加直，林哲太郎，亭島淳，松原昭郎.
小児LUTSの診断と治療へのアプローチ 尿失禁・頻尿・夜尿症-泌尿器科医の立場から-,
LUTS プライマリケア, 2011, 11 , 6-8
12. 梶原充，小畠浩平，郷力昭宏，岩本秀雄，正路晃一，沖真実，宮本克利，増本弘史，井上省吾，小林加直，大原慎也，亭島淳，松原昭郎. 64(6) , 263-264
narrow band imageを用いた潰瘍型間質性膀胱炎の内視鏡的診断法（図説）,
広島医学, 2011,
13. 梶原充，正路晃一，宮本克利，増本弘史，井上省吾，桐谷玲子，小林加直，大原慎也，亭島淳，三田耕司，松原昭郎，沖真実，森山浩之,
前立腺肥大症における過活動膀胱合併例の特徴,
西日本泌尿器科, 2011, 73(1) , 1-5
14. 梶原充, 柴田昌紀, 後藤景介, 稗田圭介, 金岡隆平, 神明俊輔, 瀬野康之, 正路晃一, 沖真実, 宮本克利, 増本弘史, 井上省吾, 小林加直, 林哲太郎, 亭島淳, 松原昭郎. 43(10) , 1784-1786
【ちょっと気になる症候のみかた考え方2011】 夜尿，頻尿,
小児内科, 2011,
15. 亭島淳，小畠浩平，岩本秀雄，郷力昭宏，沖真実，正路晃一，増本弘史，宮本克利，井上省吾，大原慎也，小林加直，梶原充，松原昭郎.
手術指導と安全確保 広島大学病院泌尿器科における腹腔鏡技術認定医育成のための手術指導と安全確保（解説）,
西日本泌尿器科, 2011, 73(4), 156-160
18. 林哲太郎，松原昭郎.
特集-ＥＡＵ/ＡＵＡ/ＡＳＣＯにおける泌尿器腫瘍のトピックス・進歩2011 尿路上皮癌,
泌尿器外科, 2011, 24(10) , 1629-1634
19. 松原昭郎，亭島淳，井上省吾.
【前立腺癌(第2版)-基礎・臨床研究のアップデート-】 臨床 前立腺癌の治療 外科治療 会陰式前立腺全摘除術,
日本臨床, 2011, 69(5) , 339-343
20. 松原昭郎，亭島淳，林哲太郎，梶原充，小林加直，井上省吾.
高度先進医療を展開しつつ前立腺癌などでユニークな業績（Columu:林先生ーCAST法を用いた前立腺癌特異的な分泌膜蛋白質 の同定と機能解析）,大学病院として幅広く，
Corre Pon Urology（ファイザー雑誌）, 2011, 64(2) , 1355-1363
